Determination of five antiarrhythmic drugs in human plasma by dispersive liquid–liquid microextraction and high-performance liquid chromatography
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- An LC–MS assay for the screening of cardiovascular medications in human samplesJournal of Chromatography B, 2013
- Direct determination of beta-blockers and their metabolites in urine by liquid chromatography coupled with tandem mass spectrometryJournal of Analytical Chemistry, 2013
- GC–MS method for the simultaneous determination of β-blockers, flavonoids, isoflavones and their metabolites in human urineJournal of Pharmaceutical and Biomedical Analysis, 2011
- Extraction and preconcentration of β-blockers in human urine for analysis with high performance liquid chromatography by means of carrier-mediated liquid phase microextractionTalanta, 2010
- Combination therapy in hypertensionJournal of the American Society of Hypertension, 2010
- A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometryAnalytica Chimica Acta, 2007
- Verapamil quantification in human plasma by liquid chromatography coupled to tandem mass spectrometryAn application for bioequivalence studyJournal of Chromatography B, 2005
- Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography–mass spectrometry with atmospheric pressure chemical ionizationJournal of Chromatography A, 2004
- HPLC determination of diltiazem in human plasma and its application to pharmacokinetics in humansBiomedical Chromatography, 2003
- Optimization of mobile phase in the separation of β-blockers by HPLCJournal of Pharmaceutical and Biomedical Analysis, 1998